Pharmicell Net Asset Quality Index
Pharmicell net asset quality index. Pharmicell (005690) has a Net Asset Quality Index of 84.9% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩130.02 Billion minus total liabilities of ₩19.60 Billion yields net assets of ₩110.43 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Pharmicell book value and equity for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Pharmicell (2010–2024)
Net asset quality index of Pharmicell from 2010 to 2024. This chart shows how Pharmicell's Net Asset Quality Index has evolved across 13 annual periods from 2010 to 2024. As of September 2025, the index stands at 84.9%, representing net assets of ₩110.43 Billion against total assets of ₩130.02 Billion KRW. Check 005690 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Pharmicell Net Asset Quality Index by Year (2010–2024)
Pharmicell net asset quality index by year from 2010 to 2024. The table below presents the year-by-year Net Asset Quality Index for Pharmicell from 2010 to 2024, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 005690 stock market capitalisation.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 87.1% | ₩86.44 Billion | ₩99.26 Billion | ₩12.83 Billion | ▲ +0.2 pp |
| 2023 | 86.9% | ₩80.40 Billion | ₩92.52 Billion | ₩12.12 Billion | ▲ +17.0 pp |
| 2022 | 69.9% | ₩76.66 Billion | ₩109.65 Billion | ₩32.98 Billion | ▲ +2.2 pp |
| 2021 | 67.7% | ₩63.87 Billion | ₩94.33 Billion | ₩30.46 Billion | ▼ -14.2 pp |
| 2020 | 81.9% | ₩57.11 Billion | ₩69.74 Billion | ₩12.64 Billion | ▲ +0.4 pp |
| 2019 | 81.4% | ₩51.52 Billion | ₩63.27 Billion | ₩11.75 Billion | ▲ +1.1 pp |
| 2018 | 80.3% | ₩47.49 Billion | ₩59.12 Billion | ₩11.63 Billion | ▼ -7.5 pp |
| 2017 | 87.8% | ₩55.99 Billion | ₩63.75 Billion | ₩7.76 Billion | ▼ -5.0 pp |
| 2016 | 92.8% | ₩94.60 Billion | ₩101.95 Billion | ₩7.36 Billion | ▲ +9.8 pp |
| 2013 | 82.9% | ₩82.42 Billion | ₩99.37 Billion | ₩16.95 Billion | ▲ +8.5 pp |
| 2012 | 74.5% | ₩101.58 Billion | ₩136.43 Billion | ₩34.84 Billion | ▼ -7.4 pp |
| 2011 | 81.9% | ₩82.82 Billion | ₩101.15 Billion | ₩18.33 Billion | ▲ +48.6 pp |
| 2010 | 33.3% | ₩9.90 Billion | ₩29.74 Billion | ₩19.84 Billion | — |